Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 485.26M P/E - EPS this Y 6.70% Ern Qtrly Grth -
Income -59.11M Forward P/E -8.50 EPS next Y 7.10% 50D Avg Chg -1.00%
Sales 306.91M PEG -0.16 EPS past 5Y 65.15% 200D Avg Chg -15.00%
Dividend N/A Price/Book 0.85 EPS next 5Y 38.90% 52W High Chg -47.00%
Recommedations 3.20 Quick Ratio 1.75 Shares Outstanding 401.36M 52W Low Chg 14.00%
Insider Own 1.54% ROA -1.27% Shares Float 383.11M Beta 2.01
Inst Own 23.79% ROE -10.30% Shares Shorted/Prior 18.19M/16.75M Price 1.19
Gross Margin 66.72% Profit Margin -19.26% Avg. Volume 2,478,600 Target Price 1.08
Oper. Margin -6.17% Earnings Date May 1 Volume 2,150,082 Change 0.00%
About Amarin Corporation plc

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Amarin Corporation plc News
03/25/24 Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
03/05/24 Amarin Full Year 2023 Earnings: Beats Expectations
03/02/24 Earnings Update: Amarin Corporation plc (NASDAQ:AMRN) Just Reported And Analysts Are Trimming Their Forecasts
03/01/24 Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates
03/01/24 Amarin Corporation plc (NASDAQ:AMRN) Q4 2023 Earnings Call Transcript
02/29/24 Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript
02/29/24 Amarin Corp PLC (AMRN) Faces Revenue Decline Amidst Generic Competition
02/29/24 Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
02/15/24 Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024
02/15/24 5 Biotech Stocks Likely to Outpace Q4 Earnings Estimates
01/22/24 Amarin Chairman & CEO Issue Letter to Shareholders
01/12/24 Are Medical Stocks Lagging Amarin (AMRN) This Year?
01/11/24 Amarin (AMRN) Stock Rises on Stellar Q4 Preliminary Results
01/10/24 Why Amarin Stock Skyrocketed Today
01/10/24 Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024
12/26/23 13 Most Promising Small-Cap Stocks According to Analysts
12/11/23 Amarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference
12/08/23 Why Is Amicus Therapeutics (FOLD) Up 15% Since Last Earnings Report?
12/05/23 What Makes Amarin (AMRN) a New Buy Stock
11/12/23 New REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl) Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with Metabolic Syndrome, but Without Diabetes at Baseline
AMRN Chatroom

User Image PotatoSalad Posted - 17 minutes ago

$AMRN highest quarter end close on the XBI in 3 years? This was what, $6 then? Cheers to more losses, see ya Monday!

User Image Novo1 Posted - 23 minutes ago

$AMRN guess ST didn’t run out of red ink

User Image Munee4Nuthn Posted - 29 minutes ago

$AMRN What I'm doing Garvey is SITTING TIGHT, just like everyone else. Vote out the board?!, that's crazy. SHIT Takes TIME, CHILL.

User Image Rickstero Posted - 48 minutes ago

$AMRN The question is who wants to keep manipulating this stock?

User Image Rickstero Posted - 52 minutes ago

$AMRN Unfortunately, the Total Shorted Shares as of 03/15/24 is now over 18 Million Shares

User Image lillylang Posted - 1 hour ago

$AMRN Gotta break LOD for the close.

User Image PhysicsbasedTrader Posted - 1 hour ago

$AMRN I estimate $50M repurchase program when in place would push this above $1.5. Beyond that point, It would be totally gamble for shorts to short. Future will be fun

User Image Blinddrunkjustice Posted - 2 hours ago

$AMRN Still in business??

User Image tomkat21 Posted - 2 hours ago

$AMRN Average is .86. Holding for the big payoff.

User Image garvey Posted - 2 hours ago

$AMRN i’m just curious what everybody’s doing with this vote nobody’s talking about it. I voted no on everything except number five. I think everybody should do the same. These board member should be voted out. We should send a clear message that we are not happy and if we don’t, we all deserve what’s going on and that’s why we’re sitting at $.80.

User Image Walls10 Posted - 3 hours ago

$AMRN Is denner finally stepping up to the plate and buying this? Because it sure as shit doesn't seem like anyone else is.

User Image DOC1977 Posted - 3 hours ago

$AMRN get this over a buck already !!!!!

User Image jblood83 Posted - 3 hours ago

$AMRN I went from being told my V Rx, for 90 day supply, would cost me $1,250, out of pocket (was told my insurer would not cover and discount card would not apply) to calling Drs. Office, insurer, and online pharmacies and getting that same 90-day supply for $0.00. Drs. Initially did not submit prior authorization. Set one to getting corrected. The pharmacy I was going to then didn't want to accept discount card (citing national hack). I spoke with insurer and asked who they work with as their Rx fulfiller and called them. The insurer Rx fulfiller accepted the V discount card and brought out of pocket to $0.00. Having Dr. Write DAW and only branded on the prior Auth. Is key.

User Image Steve_TheBull_Rogers Posted - 4 hours ago

$AMRN Cash rich, growth, amazing V, clean management now, and Alex and his fund shopping it This one is the dream biotech Added large just now, Holding til its sold

User Image Dyk_Smalls Posted - 4 hours ago

$AMRN https://www.marketwatch.com/story/wegovy-will-be-covered-by-some-insurers-but-not-for-weight-loss-report-e504321f?mod=bnbh

User Image SanDiegoLiving Posted - 5 hours ago

$AMRN KNOW WHAT YOU OWN 👀🤫 If a picture was worth 10,000 words @CaptBeer 🫡 Hey France Germany and Italy: Your health care systems are stressed, pick up your phone yah? 🤙 "It was the EPA, I'm stupid" - Steven Nissen #RaiseARedFlag 🚩

User Image steven1x Posted - 5 hours ago

$AMRN https://sl.bing.net/k8BfQ1pUJcy

User Image garvey Posted - 5 hours ago

$AMRN oh shit we’re up a half a penny, somebody must know something

User Image CaptBeer Posted - 5 hours ago

$AMRN https://x.com/nationallipid/status/1773349413953417406?s=20

User Image Walls10 Posted - 5 hours ago

$AMRN I love how denner and his board takes it over at like $1.40 saying its completely undervalued and then the stock crashes to under .80 in the next year. Nice job champs

User Image Finitemaf Posted - 6 hours ago

$AMRN this volume is laughable. Ppl really hate this stock… Announce additional approvals por favor. People sleeping on this one

User Image Finitemaf Posted - 6 hours ago

$AMRN common Denner!!!! Get this dog sold before 2025

User Image Dyk_Smalls Posted - 6 hours ago

$AMRN headed much higher imho

User Image DoMoreCharity Posted - 6 hours ago

$AMRN Apr 15(Mon) is the last day to break the Nasdaq 30 consecutive days compliance curse? Anyone can confirm?

User Image steven1x Posted - 7 hours ago

$AMRN busting out over one soon?

User Image bankswapsmarket Posted - 9 hours ago

$AMRN look kids there’s Big Ben and Parliament 5 years running 🚗 😞

User Image Nerikcr Posted - 10 hours ago

$AMRN Bet if AMRN made the same acquisition as AVTX just did, AMRN stock still wouldn't move.

User Image DoMoreCharity Posted - 15 hours ago

$AMRN https://www.etfdailynews.com/2024/03/26/zacks-research-analysts-boost-earnings-estimates-for-amarin-co-plc-nasdaqamrn/

User Image DoMoreCharity Posted - 15 hours ago

$AMRN

User Image DoMoreCharity Posted - 17 hours ago

$AMRN

Analyst Ratings
Jefferies Hold Oct 25, 23
Goldman Sachs Sell Jul 20, 23
Northland Capital Markets Market Perform Jul 19, 23
Jefferies Buy Jan 6, 23
SVB Leerink Market Perform Oct 19, 22
Goldman Sachs Sell May 24, 22
JP Morgan Underweight May 6, 22
HC Wainwright & Co. Neutral May 5, 22
SVB Leerink Market Perform May 5, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Ketchum Steven B Chief Scientific Off.. Chief Scientific Officer Dec 12 Sell 0.79 34,131 26,963 566,100 12/14/23
Holt Patrick President and CEO President and CEO Aug 16 Buy 1.04 300,000 312,000 300,000 08/16/23
WOLD OLSEN PER Director Director Jun 13 Buy 1.686 55,000 92,730 149,000 06/15/22
STACK DAVID M Director Director Jun 07 Buy 4.58 15,000 68,700 40,000 06/07/21
Ketchum Steven B Chief Scientific Off.. Chief Scientific Officer Feb 03 Option 2.65 192,358 509,749 600,724 02/03/21
Ketchum Steven B Chief Scientific Off.. Chief Scientific Officer Feb 03 Sell 8.04 217,728 1,750,533 382,996 02/03/21
Ketchum Steven B Chief Scientific Off.. Chief Scientific Officer Jan 29 Option 2.4 278,237 667,769 809,741 01/29/21
Ketchum Steven B Chief Scientific Off.. Chief Scientific Officer Jan 29 Sell 8.01 421,629 3,377,248 388,112 01/29/21
THERO JOHN F President and CEO President and CEO Nov 12 Option 3.4 750,000 2,550,000 3,306,405 11/12/20
THERO JOHN F President and CEO President and CEO Nov 12 Sell 4.1 567,405 2,326,360 2,739,000 11/12/20